Product class:
|
Authorized package
|
Medicinal product class:
|
Veterinary medicine
|
Package code:
|
1873706
|
Name of medicinal product:
|
CircoMax
|
Active substances:
|
|
ATC code:
|
QI09AA07
|
Dosage form:
|
emulsion for injection
|
Route of administration:
|
intramuscular use
|
Strengh:
|
|
Amount in package:
|
125annus 1TK
|
Legal status for supply*:
|
Subject to medicinal prescription
|
Class of active substance:
|
|
Additional information:
|
|
Indication:
|
Active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid
tissues, fecal shedding and the lesions in lymphoid tissues associated with PCV2 infection. Protection was
demonstrated against porcine circovirus types 2a, 2b and 2d.
Onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination.
Duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination.
|
Safety features:
|
No
|
Summary of product characteristics (SPC):
|
|
Package information leaflet (PIL):
|
EST
|
Labelling:
|
|
Withdrawal time:
|
|
Species:
|
siga (nuumsiga)
|
Last imported to Estonia:
|
Never imported to Estonia
|
Marketing authorization holder:
|
Zoetis Belgium
|
Marketing authorization number:
|
EU/2/21/281
|
Marketing authorization issued on:
|
January 11, 2022
|
Marketing authorization expires on:
|
January 12, 2027
|
Marketing authorization procedure type:
|
Centralised
|
Entry/Changing date:
August 24, 2023
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere